High Prevalence of Serine Protease Inhibitor Kazal Type 1 Gene Variations Detected by Whole Gene Sequencing in Patients with Fibrocalculous Pancreatic Diabetes

AIM OF STUDY: The aim is to study the prevalence and pattern of serine protease inhibitor Kazal type 1 (SPINK1) gene variations in patients with fibrocalculous pancreatic diabetes (FCPD) using whole gene sequencing. MATERIALS AND METHODS: A total of 56 consecutive patients of FCPD were recruited for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolly, Anish, Shivaprasad, C., Pulikkal, Annie A., Atluri, Sridevi, Sarathi, Vijaya, Dwarakanath, C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477435/
https://www.ncbi.nlm.nih.gov/pubmed/28670531
http://dx.doi.org/10.4103/ijem.IJEM_116_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477435/
https://www.ncbi.nlm.nih.gov/pubmed/28670531
http://dx.doi.org/10.4103/ijem.IJEM_116_17

Ejemplares similares